Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Conditions: Sarcoma, Ewing; Rhabdomyosarcoma Interventions: Drug: PEN-866; Drug: Vincristine; Drug: Temozolomide Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2021 Category: Research Source Type: clinical trials
Phase 1/2 Study of Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors
Conditions: Sarcoma, Ewing; Rhabdomyosarcoma Interventions: Drug: PEN-866; Drug: Vincristine; Drug: Temozolomide Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2021 Category: Research Source Type: clinical trials
Indo-cyanine Green (ICG) in Paediatric Oncology MIS
Conditions: Pediatric Renal Tumor; Metastatic Osteosarcoma; Metastatic Ewing Sarcoma; Pulmonary Metastasis; Rhabdomyosarcoma; Non-Rhabdo. Soft Tissue Sarcoma Intervention: Drug: Indocyanine green Sponsor: Birmingham Women's and Children's NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2021 Category: Research Source Type: clinical trials
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Conditions: Solid Tumors; Soft Tissue Sarcoma; Ewing Sarcoma; Malignant Epithelial Neoplasm; Rhabdomyosarcoma; Wilms Tumor; Hepatic Tumor; Germ Cell Tumor; Bone Metastases Interventions: Device: Magnetic Resonance-Guided High Intensity Focused Ultrasound; Drug: Lyso-thermosensitive Liposomal Doxorubicin Sponsor: Children's National Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2021 Category: Research Source Type: clinical trials
